0001123292-19-000751.txt : 20190513 0001123292-19-000751.hdr.sgml : 20190513 20190513193249 ACCESSION NUMBER: 0001123292-19-000751 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190513 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khuong Chau Quang CENTRAL INDEX KEY: 0001609405 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38905 FILM NUMBER: 19820101 MAIL ADDRESS: STREET 1: C/O ORBIMED ADVISORS STREET 2: 601 LEXINGTON AVENUE, 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NextCure, Inc. CENTRAL INDEX KEY: 0001661059 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475231247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-399-4900 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-05-13 0001661059 NextCure, Inc. NXTC 0001609405 Khuong Chau Quang C/O NEXTCURE, INC. 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 1 0 0 0 Common Stock 2019-05-13 4 C 0 445866 A 445866 I By OrbiMed Private Investments VI, LP Common Stock 2019-05-13 4 C 0 743110 A 1188976 I By OrbiMed Private Investments VI, LP Common Stock 2019-05-13 4 C 0 729599 A 1918575 I By OrbiMed Private Investments VI, LP Common Stock 2019-05-13 4 C 0 442438 A 2361013 I By OrbiMed Private Investments VI, LP Common Stock 2019-05-13 4 P 0 350000 15.00 A 2711013 I By OrbiMed Private Investments VI, LP Series A-1 Preferred Stock 2019-05-13 4 C 0 3582000 D Common Stock 445866 0 I By OrbiMed Private Investments VI, LP Series A-2 Preferred Stock 2019-05-13 4 C 0 5970000 D Common Stock 743110 0 I By OrbiMed Private Investments VI, LP Series A-3 Preferred Stock 2019-05-13 4 C 0 5861455 D Common Stock 729599 0 I By OrbiMed Private Investments VI, LP Series B-1 Preferred Stock 2019-05-13 4 C 0 3554466 D Common Stock 442438 0 I By OrbiMed Private Investments VI, LP The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date. OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. The Reporting Person is an employee of OrbiMed Advisors. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein. Each of GP VI, OrbiMed Advisors and the Reporting Person disclaims beneficial ownership of the shares held by OPI VI, except to the extent of its or his pecuniary interest therein, if any. /s/ Chau Q. Khuong 2019-05-13